Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma
Clinical trial NCT01078142 · COMPLETED
Trial details
- NCT number
- NCT01078142
- Sponsor
- Georg Hess, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-02
- Primary completion
- 2017-09-08
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.